{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:42:47Z","timestamp":1760132567141,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":170,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493990764"},{"type":"electronic","value":"9781493990771"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9077-1_15","type":"book-chapter","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T03:41:27Z","timestamp":1548992487000},"page":"225-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection"],"prefix":"10.1007","author":[{"given":"William J.","family":"Scotton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abid","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiju","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,2]]},"reference":[{"key":"15_CR1","first-page":"33","volume":"62","author":"E Florey","year":"1954","unstructured":"Florey E (1954) An inhibitory and an excitatory factor of mammalian central nervous system, and their action of a single sensory neuron. Arch Int Physiol 62:33\u201353","journal-title":"Arch Int Physiol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1152\/jn.1954.17.6.558","volume":"17","author":"SW Kuffler","year":"1954","unstructured":"Kuffler SW (1954) Mechanisms of activation and motor control of stretch receptors in lobster and crayfish. J Neurophysiol 17:558\u2013574","journal-title":"J Neurophysiol"},{"issue":"6545","key":"15_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/377115a0","volume":"377","author":"RA Nicoll","year":"1995","unstructured":"Nicoll RA,\u00a0Malenka RC (1995) Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature\u00a0377(6545):115\u2013118","journal-title":"Nature"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1293\/tox.21.25","volume":"21","author":"CG Rousseaux","year":"2008","unstructured":"Rousseaux CG (2008) A review of glutamate receptors I: current understanding of their biology. J Toxicol Pathol 21:25\u201351","journal-title":"J Toxicol Pathol"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1258\/acb.2011.011140","volume":"49","author":"AR Karim","year":"2012","unstructured":"Karim AR, Jacob S (2012) Immunological markers in neurological disorders. Ann Clin Biochem 49:29\u201343","journal-title":"Ann Clin Biochem"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00702-014-1193-3","volume":"121","author":"M Levite","year":"2014","unstructured":"Levite M (2014) Glutamate receptor antibodies in neurological diseases. J Neural Transm 121:1029\u20131075","journal-title":"J Neural Transm"},{"issue":"10","key":"15_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fnmol.2017.00451","volume":"17","author":"CR Rose","year":"2018","unstructured":"Rose CR, Felix L, Zeug A et al (2018) Astroglial glutamate signaling and uptake in the hippocampus. Front Mol Neurosci 17(10):451","journal-title":"Front Mol Neurosci"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1476-5381.1963.tb01484.x","volume":"20","author":"K Krnjevir","year":"1963","unstructured":"Krnjevir K, Phillis JW (1963) Actions of certain amines on cerebral cortical neurones. Br J Pharmacol Chemother 20:471\u2013490","journal-title":"Br J Pharmacol Chemother"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1113\/jphysiol.1963.sp007057","volume":"165","author":"K Krnjevic","year":"1963","unstructured":"Krnjevic K, Phillis JW (1963) Iontophoretic studies of neurones in the mammalian cerebral cortex. J Physiol 165:274\u2013304","journal-title":"J Physiol"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.pa.21.040181.001121","volume":"21","author":"JC Watkins","year":"1981","unstructured":"Watkins JC, Evans RH (1981) Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 21:165\u2013204","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"15_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0301-0082(87)90011-6","volume":"28","author":"ML Mayer","year":"1987","unstructured":"Mayer ML, Westbrook GL (1987) The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28(3):197\u2013276","journal-title":"Prog Neurobiol"},{"key":"15_CR12","first-page":"143","volume":"41","author":"GL Collingridge","year":"1989","unstructured":"Collingridge GL, Lester RA (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 41:143\u2013210","journal-title":"Pharmacol Rev"},{"issue":"6407","key":"15_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TV Bliss","year":"1993","unstructured":"Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361(6407):31\u201339","journal-title":"Nature"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/syn.890060306","volume":"6","author":"PF Chapman","year":"1990","unstructured":"Chapman PF, Kairiss EW, Keenan CL et al (1990) Long-term synaptic potentiation in the amygdala. Synapse 6:271\u2013278","journal-title":"Synapse"},{"issue":"1","key":"15_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0014-2999(94)90624-6","volume":"256","author":"V Bruno","year":"1994","unstructured":"Bruno V, Copani A, Battaglia G et al (1994) Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur J Pharmacol 256(1):109\u2013112","journal-title":"Eur J Pharmacol"},{"issue":"5060","key":"15_CR16","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.256.5060.1217","volume":"256","author":"H Monyer","year":"1992","unstructured":"Monyer H, Sprengel R, Schoepfer R et al (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256(5060):1217\u20131221","journal-title":"Science"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.ne.17.030194.000335","volume":"17","author":"M Hollmann","year":"1994","unstructured":"Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31\u2013108","journal-title":"Annu Rev Neurosci"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.bb.23.060194.001535","volume":"23","author":"S Nakanishi","year":"1994","unstructured":"Nakanishi S, Masu M (1994) Molecular diversity and functions of glutamate receptors. Annu Rev Biophys Biomol Struct 23:319\u2013348","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"1","key":"15_CR19","first-page":"7","volume":"51","author":"R Dingledine","year":"1999","unstructured":"Dingledine R, Borges K, Bowie D et al (1999) The glutamate receptor ion channels. Pharmacol Rev 51(1):7\u201361","journal-title":"Pharmacol Rev"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02740744","volume":"12","author":"F Aszt\u00e9ly","year":"1996","unstructured":"Aszt\u00e9ly F, Gustafsson B (1996) Ionotropic glutamate receptors. Their possible role in the expression of hippocampal synaptic plasticity. Mol Neurobiol 12:1\u201311","journal-title":"Mol Neurobiol"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1749-6632.1995.tb17506.x","volume":"757","author":"S Miller","year":"1995","unstructured":"Miller S, Kesslak JP, Romano C et al (1995) Roles of metabotropic glutamate receptors in brain plasticity and pathology. Ann N Y Acad Sci 757:460\u2013474","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"15_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0301-0082(97)00085-3","volume":"54","author":"S Ozawa","year":"1998","unstructured":"Ozawa S, Kamiya H, Tsuzuki K (1998) Glutamate receptors in the mammalian nervous system. Prog Neurobiol 54(5):581\u2013618","journal-title":"Prog Neurobiol"},{"issue":"3","key":"15_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0024-3205(94)00583-4","volume":"54","author":"MD Cunningham","year":"1994","unstructured":"Cunningham MD, Ferkany JW, Enna SJ (1994) Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention. Life Sci 54(3):135\u2013148","journal-title":"Life Sci"},{"key":"15_CR24","first-page":"518","volume":"251","author":"HE Shannon","year":"1989","unstructured":"Shannon HE, Sawyer BD (1989) Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum. J Pharmacol Exp Ther 251:518\u2013523","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","volume":"37","author":"PJ Conn","year":"1997","unstructured":"Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205\u2013237","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/187152708784083821","volume":"7","author":"D Bowie","year":"2008","unstructured":"Bowie D (2008) Ionotropic glutamate receptors & CNS disorders. CNS Neurol Disord Drug Targets 7:129\u2013143","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"15_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.conb.2011.02.001","volume":"21","author":"ML Mayer","year":"2011","unstructured":"Mayer ML (2011) Structure and mechanism of glutamate receptor ion channel assembly, activation and modulation. Curr Opin Neurobiol 21(2):283\u2013290","journal-title":"Curr Opin Neurobiol"},{"issue":"10","key":"15_CR28","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.str.2011.08.009","volume":"19","author":"ML Mayer","year":"2011","unstructured":"Mayer ML (2011) Emerging models of glutamate receptor ion channel structure and function. Structure 19(10):1370\u20131380","journal-title":"Structure"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1113\/jphysiol.2013.264911","volume":"5931","author":"AI Sobolevsky","year":"2015","unstructured":"Sobolevsky AI (2015) Structure and gating of tetrameric glutamate receptors. J Physiol 5931:29\u201338","journal-title":"J Physiol"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/bs.apha.2017.08.005","volume":"82","author":"DR Lynch","year":"2018","unstructured":"Lynch DR, Rattelle A, Dong YN et al (2018) Anti-NMDA receptor encephalitis: clinical features and basic mechanisms. Adv Pharmacol 82:235\u2013260","journal-title":"Adv Pharmacol"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.sbi.2015.07.012","volume":"33","author":"MC Regan","year":"2015","unstructured":"Regan MC, Romero-Hernandez A, Furukawa H (2015) A structural biology perspective on NMDA receptor pharmacology and function. Curr Opin Struct Biol 33:68\u201375","journal-title":"Curr Opin Struct Biol"},{"issue":"3","key":"15_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, Mcbain CJ et al (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405\u2013496","journal-title":"Pharmacol Rev"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coph.2014.10.009","volume":"20","author":"S Zhu","year":"2015","unstructured":"Zhu S, Paoletti P (2015) Allosteric modulators of NMDA receptors: multiple sites and mechanisms. Curr Opin Pharmacol 20:14\u201323","journal-title":"Curr Opin Pharmacol"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.256.5060.1217","volume":"256","author":"H Monyer","year":"1992","unstructured":"Monyer H, Sprengel R, Schoepfer R et al (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217\u20131221","journal-title":"Science"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1038\/emboj.2009.338","volume":"28","author":"E Karakas","year":"2009","unstructured":"Karakas E, Simorowski N, Furukawa H (2009) Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 28:3910\u20133920","journal-title":"EMBO J"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F (2017) Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 97:839\u2013887","journal-title":"Physiol Rev"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","volume":"32","author":"AJ Gleichman","year":"2012","unstructured":"Gleichman AJ, Spruce LA, Dalmau J et al (2012) Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 32:11082\u201311094","journal-title":"J Neurosci"},{"issue":"6076","key":"15_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/322265a0","volume":"322","author":"CE Herron","year":"1986","unstructured":"Herron CE, Lester RA, Coan EJCG (1986) Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature 322(6076):265\u2013268","journal-title":"Nature"},{"issue":"16","key":"15_CR39","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1073\/pnas.93.16.8648","volume":"93","author":"J Kupper","year":"1996","unstructured":"Kupper J, Ascher P, Neytont J (1996) Probing the pore region of recombinant N-methyl-D-aspartate channels using external and internal magnesium block. Proc Natl Acad Sci U S A 93(16):8648\u20138653","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0896-6273(94)90350-6","volume":"13","author":"D Forrest","year":"1994","unstructured":"Forrest D, Yuzaki M, Soares HD et al (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13:325\u2013338","journal-title":"Neuron"},{"issue":"21","key":"15_CR41","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.1523\/JNEUROSCI.16-21-06634.1996","volume":"16","author":"KM Partin","year":"1996","unstructured":"Partin KM, Fleck MW, Mayer ML (1996) AMPA receptor flip\/flop mutants affecting deactivation, desensitization, and modulation by Cyclothiazide, Aniracetam, and Thiocyanate. J Neurosci 16(21):6634\u20136647","journal-title":"J Neurosci"},{"issue":"1","key":"15_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1476-5381.1993.tb13556.x","volume":"109","author":"CG Parsons","year":"1993","unstructured":"Parsons CG, Zong X, Lux HD (1993) Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. Br J Pharmacol 109(1):213\u2013221","journal-title":"Br J Pharmacol"},{"issue":"7112","key":"15_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature05123","volume":"443","author":"AE Ch\u00e1vez","year":"2006","unstructured":"Ch\u00e1vez AE, Singer JH, Diamond JS (2006) Fast neurotransmitter release triggered by Ca influx through AMPA-type glutamate receptors. Nature 443(7112):705\u2013708","journal-title":"Nature"},{"issue":"4976","key":"15_CR44","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1126\/science.1699275","volume":"249","author":"B Sommer","year":"1990","unstructured":"Sommer B, Kein\u00e4nen K, Verdoorn TA et al (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249(4976):1580\u20131585","journal-title":"Science"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1146\/annurev.cellbio.23.090506.123516","volume":"23","author":"JD Shepherd","year":"2007","unstructured":"Shepherd JD, Huganir RL (2007) The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 23:613\u2013643","journal-title":"Annu Rev Cell Dev Biol"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1126\/science.280.5369.1596","volume":"280","author":"C Rosenmund","year":"1998","unstructured":"Rosenmund C, Stern-Bach Y, Stevens CF (1998) The tetrameric structure of a glutamate receptor channel. Science 280:1596\u20131599","journal-title":"Science"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.conb.2005.05.004","volume":"15","author":"ML Mayer","year":"2005","unstructured":"Mayer ML (2005) Glutamate receptor ion channels. Curr Opin Neurobiol 15:282\u2013288","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"15_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/pr.57.2.7","volume":"57","author":"CL Palmer","year":"2005","unstructured":"Palmer CL, Cotton L, Henley JM (2005) The molecular pharmacology and cell biology of \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev 57(2):253\u2013277","journal-title":"Pharmacol Rev"},{"issue":"1","key":"15_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0896-6273(95)90076-4","volume":"15","author":"JR Geiger","year":"1995","unstructured":"Geiger JR, Melcher T, Koh DS et al (1995) Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15(1):193\u2013204","journal-title":"Neuron"},{"issue":"28","key":"15_CR50","doi-asserted-by":"publisher","first-page":"9367","DOI":"10.1523\/JNEUROSCI.23-28-09367.2003","volume":"23","author":"N Sans","year":"2003","unstructured":"Sans N, Vissel B, Petralia RS et al (2003) Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. J Neurosci 23(28):9367\u20139373","journal-title":"J Neurosci"},{"issue":"6","key":"15_CR51","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1523\/JNEUROSCI.16-06-01982.1996","volume":"16","author":"RJ Wenthold","year":"1996","unstructured":"Wenthold RJ, Petralia RS, Niedzielski AS (1996) Evidence for multiple AMPA receptor complexes in hippocampal CA1\/CA2 neurons. J Neurosci 16(6):1982\u20131989","journal-title":"J Neurosci"},{"issue":"2","key":"15_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00441-006-0275-4","volume":"326","author":"R Sprengel","year":"2006","unstructured":"Sprengel R (2006) Role of AMPA receptors in synaptic plasticity. Cell Tissue Res 326(2):447\u2013455","journal-title":"Cell Tissue Res"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0028-3908(97)00158-5","volume":"36","author":"M Vignes","year":"1997","unstructured":"Vignes M, Bleakman D, Lodge D et al (1997) The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus. Neuropharmacology 36:1477\u20131481","journal-title":"Neuropharmacology"},{"issue":"3","key":"15_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1152\/physrev.2001.81.3.971","volume":"81","author":"J Lerma","year":"2001","unstructured":"Lerma J, Paternain AV, Rodriguez A et al (2001) Molecular physiology of Kainate receptors. Physiol Rev 81(3):971\u2013998","journal-title":"Physiol Rev"},{"issue":"1","key":"15_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuropharm.2008.06.063","volume":"56","author":"GL Collingridge","year":"2009","unstructured":"Collingridge GL, Olsen RW, Peters J et al (2009) A nomenclature for ligand-gated ion channels. Neuropharmacology 56(1):2\u20135","journal-title":"Neuropharmacology"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1126\/science.2166337","volume":"249","author":"K Kein\u00e4nen","year":"1990","unstructured":"Kein\u00e4nen K, Wisden W, Sommer B et al (1990) A family of AMPA-selective glutamate receptors. Science 249:556\u2013560","journal-title":"Science"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coph.2005.08.004","volume":"6","author":"J Lerma","year":"2006","unstructured":"Lerma J (2006) Kainate receptor physiology. Curr Opin Pharmacol 6:89\u201397","journal-title":"Curr Opin Pharmacol"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0165-6147(98)01286-3","volume":"20","author":"R Chittajallu","year":"1999","unstructured":"Chittajallu R, Braithwaite SP, Clarke VR et al (1999) Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol Sci 20:26\u201335","journal-title":"Trends Pharmacol Sci"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1515\/znc-2002-3-425","volume":"57","author":"H Ohashi","year":"2002","unstructured":"Ohashi H, Maruyama T, Higashi-Matsumoto H et al (2002) A novel binding assay for metabotropic glutamate receptors using [3H] L-quisqualic acid and recombinant receptors. Z Naturforsch C 57:348\u2013355","journal-title":"Z Naturforsch C"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0197-0186(00)00075-9","volume":"38","author":"E Hinoi","year":"2001","unstructured":"Hinoi E, Ogita K, Takeuchi Y et al (2001) Characterization with [3H]quisqualate of group I metabotropic glutamate receptor subtype in rat central and peripheral excitable tissues. Neurochem Int 38:277\u2013285","journal-title":"Neurochem Int"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0006-8993(00)02752-9","volume":"879","author":"Z Chu","year":"2000","unstructured":"Chu Z, Hablitz JJ (2000) Quisqualate induces an inward current via mGluR activation in neocortical pyramidal neurons. Brain Res 879:88\u201392","journal-title":"Brain Res"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295\u2013322","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0197-0186(94)90092-2","volume":"24","author":"DD Schoepp","year":"1994","unstructured":"Schoepp DD (1994) Novel functions for subtypes of metabotropic glutamate receptors. Neurochem Int 24:439\u2013449","journal-title":"Neurochem Int"},{"key":"15_CR64","first-page":"325","volume":"47","author":"T Narahashi","year":"1992","unstructured":"Narahashi T, Arakawa O, Brunner EA et al (1992) Modulation of GABA receptor-channel complex by alcohols and general anesthetics. Adv Biochem Psychopharmacol 47:325\u2013334","journal-title":"Adv Biochem Psychopharmacol"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","volume":"75","author":"J Cartmell","year":"2000","unstructured":"Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889\u2013907","journal-title":"J Neurochem"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","volume":"179","author":"JNC Kew","year":"2005","unstructured":"Kew JNC, Kemp JA (2005) Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179:4\u201329","journal-title":"Psychopharmacology"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nrn.2015.27","volume":"17","author":"SJ Crisp","year":"2016","unstructured":"Crisp SJ, Kullmann DM, Vincent A (2016) Autoimmune synaptopathies. Nat Rev Neurosci 17:103\u2013117","journal-title":"Nat Rev Neurosci"},{"issue":"16","key":"15_CR68","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349(16):1543\u20131554","journal-title":"N Engl J Med"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","volume":"298","author":"DB Drachman","year":"1978","unstructured":"Drachman DB, Angus CW, Adams RN et al (1978) Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 298:1116\u20131122","journal-title":"N Engl J Med"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1056\/NEJM198209233071301","volume":"307","author":"DB Drachman","year":"1982","unstructured":"Drachman DB, Adams RN, Josifek LF et al (1982) Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 307:769\u2013775","journal-title":"N Engl J Med"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ana.410240412","volume":"24","author":"A Nagel","year":"1988","unstructured":"Nagel A, Engel AG, Lang B et al (1988) Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation. Ann Neurol 24:552\u2013558","journal-title":"Ann Neurol"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ana.410420204","volume":"42","author":"SA Waterman","year":"1997","unstructured":"Waterman SA, Lang B, Newsom-Davis J (1997) Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 42:147\u2013156","journal-title":"Ann Neurol"},{"key":"15_CR73","first-page":"854","volume":"53","author":"J Casper","year":"1928","unstructured":"Casper J (1928) Subacute cortical cerebellar degeneration associated with carcinoma. Zbl ges Neurol Psychiat 53:854","journal-title":"Zbl ges Neurol Psychiat"},{"issue":"2","key":"15_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jnnp.14.2.59","volume":"14","author":"WR Brain","year":"1951","unstructured":"Brain WR, Daniel PM, Greenfield JG (1951) Subacute cortical cerebellar degeneration and its relation to carcinoma. J Neurol Neurosurg Psychiatry 14(2):59\u201375","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"15_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/91.3.481","volume":"91","author":"JA Corsellis","year":"1968","unstructured":"Corsellis JA, Goldberg GJ, Norton AR (1968) \u201cLimbic encephalitis\u201d and its association with carcinoma. Brain 91(3):481\u2013496","journal-title":"Brain"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1212\/WNL.35.4.538","volume":"35","author":"F Graus","year":"1985","unstructured":"Graus F, Cordon-Cardo C, Posner JB (1985) Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35:538\u2013543","journal-title":"Neurology"},{"issue":"4","key":"15_CR77","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7(4):327\u2013340","journal-title":"Lancet Neurol"},{"issue":"2","key":"15_CR78","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1460-9568.2010.07349.x","volume":"32","author":"EH Moscato","year":"2010","unstructured":"Moscato EH, Jain A, Peng X et al (2010) Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci 32(2):298\u2013309","journal-title":"Eur J Neurosci"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ana.1097","volume":"50","author":"C Buckley","year":"2001","unstructured":"Buckley C, Oger J, Clover L et al (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50:73\u201378","journal-title":"Ann Neurol"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/brain\/awh077","volume":"127","author":"A Vincent","year":"2004","unstructured":"Vincent A, Buckley C, Schott JM et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701\u2013712","journal-title":"Brain"},{"issue":"9","key":"15_CR81","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133(9):2734\u20132748","journal-title":"Brain"},{"issue":"4","key":"15_CR82","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ana.20614","volume":"58","author":"R Vitaliani","year":"2005","unstructured":"Vitaliani R, Mason W, Ances B et al (2005) Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58(4):594\u2013604","journal-title":"Ann Neurol"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/brain\/awh526","volume":"128","author":"BM Ances","year":"2005","unstructured":"Ances BM, Vitaliani R, Taylor RA et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764\u20131777","journal-title":"Brain"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10096-009-0799-0","volume":"28","author":"MS Gable","year":"2009","unstructured":"Gable MS, Gavali S, Radner A et al (2009) Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 28:1421\u20131429","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu H et al (2007) Paraneoplastic anti- N -methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25\u201336","journal-title":"Ann Neurol"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424\u2013434","journal-title":"Ann Neurol"},{"issue":"17","key":"15_CR87","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R H\u00f6ftberger","year":"2013","unstructured":"H\u00f6ftberger R, Titulaer MJ, Sabater L et al (2013) Encephalitis and GABA B receptor antibodies novel findings in a new case series of 20 patients. Neurology 81(17):1500\u20131506","journal-title":"Neurology"},{"key":"15_CR88","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","volume":"81","author":"OJ Jeffery","year":"2013","unstructured":"Jeffery OJ, Lennon VA, Pittock SJ et al (2013) GABAB receptor autoantibody frequency in service serologic evaluation. Neurology 81:882\u2013887","journal-title":"Neurology"},{"issue":"1","key":"15_CR89","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABA B receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9(1):67\u201376","journal-title":"Lancet Neurol"},{"issue":"3","key":"15_CR90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X et al (2014) Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABA A receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 13(3):276\u2013286","journal-title":"Lancet Neurol"},{"key":"15_CR91","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/brain\/awu142","volume":"137","author":"A Carvajal-Gonz\u00e1 Lez","year":"2014","unstructured":"Carvajal-Gonz\u00e1 Lez A, Leite MI, Waters P et al (2014) Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 137:2178\u20132192","journal-title":"Brain"},{"key":"15_CR92","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","volume":"73","author":"E Martinez-Hernandez","year":"2016","unstructured":"Martinez-Hernandez E, Ari\u00f1o H, McKeon A et al (2016) Clinical and immunologic investigations in patients with stiff-person spectrum disorder. JAMA Neurol 73:714\u2013720","journal-title":"JAMA Neurol"},{"issue":"18","key":"15_CR93","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ et al (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77(18):1698\u20131701","journal-title":"Neurology"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586","journal-title":"Lancet Neurol"},{"key":"15_CR95","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, H\u00f6ftberger R, Graus F et al (2016) Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol 132:531\u2013543","journal-title":"Acta Neuropathol"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/archneurol.2010.51","volume":"67","author":"R Marignier","year":"2010","unstructured":"Marignier R, Chenevier F, Rogemond V et al (2010) Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease? Arch Neurol 67:627\u2013630","journal-title":"Arch Neurol"},{"key":"15_CR97","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"PS Smitt","year":"2000","unstructured":"Smitt PS, Kinoshita A, De Leeuw B et al (2000) Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 342:21\u201327","journal-title":"N Engl J Med"},{"key":"15_CR98","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/brain\/aws256","volume":"135","author":"RC Dale","year":"2012","unstructured":"Dale RC, Merheb V, Pillai S et al (2012) Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135:3453\u20133468","journal-title":"Brain"},{"key":"15_CR99","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","volume":"73","author":"A Boronat","year":"2013","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N et al (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73:120\u2013128","journal-title":"Ann Neurol"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1056\/NEJMc0909510","volume":"362","author":"MH Cheng","year":"2010","unstructured":"Cheng MH, Fan U, Grewal N et al (2010) Acquired autoimmune polyglandular syndrome, thymoma, and an AIRE defect. N Engl J Med 362:764\u2013766","journal-title":"N Engl J Med"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2249.2008.03739.x","volume":"154","author":"A Meager","year":"2008","unstructured":"Meager A, Peterson P, Willcox N (2008) Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes. Clin Exp Immunol 154:141\u2013151","journal-title":"Clin Exp Immunol"},{"key":"15_CR102","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/cmi.2010.74","volume":"8","author":"S Shelly","year":"2011","unstructured":"Shelly S, Agmon-Levin N, Altman A et al (2011) Thymoma and autoimmunity. Cell Mol Immunol 8:199\u2013202","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"15_CR103","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17925\/ENR.2013.08.01.31","volume":"8","author":"F Leypoldt","year":"2013","unstructured":"Leypoldt F, Wandinger KP, Bien CG et al (2013) Autoimmune encephalitis. Eur Neurol Rev 8(1):31\u201337","journal-title":"Eur Neurol Rev"},{"issue":"6","key":"15_CR104","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","volume":"77","author":"E Martinez-Hernandez","year":"2011","unstructured":"Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y et al (2011) Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 77(6):589\u2013593","journal-title":"Neurology"},{"issue":"8","key":"15_CR105","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/brain\/awy109","volume":"141","author":"Sophie Binks","year":"2018","unstructured":"Binks S, Varley J, Lee W et al (2018) Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain. \n                    https:\/\/doi.org\/10.1093\/brain\/awy109","journal-title":"Brain"},{"key":"15_CR106","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/dmcn.13420","volume":"59","author":"HF Jones","year":"2017","unstructured":"Jones HF, Mohammad SS, Reed PW et al (2017) Anti- N -methyl- d -aspartate receptor encephalitis in M\u0101ori and Pacific Island children in New Zealand. Dev Med Child Neurol 59:719\u2013724","journal-title":"Dev Med Child Neurol"},{"key":"15_CR107","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/ana.25216","volume":"83","author":"SH Mueller","year":"2018","unstructured":"Mueller SH, F\u00e4rber A, Pr\u00fcss H et al (2018) Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Ann Neurol 83:863\u2013869","journal-title":"Ann Neurol"},{"key":"15_CR108","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR109","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","volume":"118","author":"E T\u00fcz\u00fcn","year":"2009","unstructured":"T\u00fcz\u00fcn E, Zhou L, Baehring JM et al (2009) Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 118:737\u2013743","journal-title":"Acta Neuropathol"},{"key":"15_CR110","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.25173","volume":"83","author":"M Makuch","year":"2018","unstructured":"Makuch M, Wilson R, Al-Diwani A et al (2018) N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications. Ann Neurol 83:553\u2013561","journal-title":"Ann Neurol"},{"key":"15_CR111","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091\u20131098","journal-title":"Lancet Neurol"},{"key":"15_CR112","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24083","volume":"75","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, M\u00e1laga I et al (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75:317\u2013323","journal-title":"Ann Neurol"},{"key":"15_CR113","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jpeds.2012.10.011","volume":"162","author":"T Armangue","year":"2013","unstructured":"Armangue T, Titulaer MJ, M\u00e1laga I et al (2013) Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 162:850\u2013856.e2","journal-title":"J Pediatr"},{"key":"15_CR114","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ana.23689","volume":"72","author":"H Pr\u00fcss","year":"2012","unstructured":"Pr\u00fcss H, Finke C, H\u00f6ltje M et al (2012) N-methyl- D -aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72:902\u2013911","journal-title":"Ann Neurol"},{"key":"15_CR115","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1212\/WNL.0000000000001072","volume":"83","author":"W-R Schabitz","year":"2014","unstructured":"Schabitz W-R, Rogalewski A, Hagemeister C et al (2014) VZV brainstem encephalitis triggers NMDA receptor immunoreaction. Neurology 83:2309\u20132311","journal-title":"Neurology"},{"key":"15_CR116","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10096-009-0799-0","volume":"28","author":"MS Gable","year":"2009","unstructured":"Gable MS, Gavali S, Radner A et al (2009) Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 28:1421\u20131429","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"15_CR117","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1212\/NXI.0000000000000458","volume":"5","author":"A Salovin","year":"2018","unstructured":"Salovin A, Glanzman J, Roslin K et al (2018) Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurol Neuroimmunol neuroinflamm 5:e458","journal-title":"Neurol Neuroimmunol neuroinflamm"},{"issue":"23","key":"15_CR118","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1212\/WNL.0000000000003414","volume":"87","author":"J Dalmau","year":"2016","unstructured":"Dalmau J (2016) NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias lecture. Neurology 87(23):2471\u20132482","journal-title":"Neurology"},{"key":"15_CR119","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"15_CR120","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod J, Ambrose HE, Davies NW et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835\u2013844","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"15_CR121","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A et al (2014) Diagnosis and significance of antibody titers in anti-NMDA receptor encephalitis, a retrospective study. Lancet Neurol 13(2):167\u2013177","journal-title":"Lancet Neurol"},{"key":"15_CR122","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/brain\/aww208","volume":"139","author":"J Kreye","year":"2016","unstructured":"Kreye J, Wenke NK, Chayka M et al (2016) Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain 139:2641\u20132652","journal-title":"Brain"},{"issue":"7","key":"15_CR123","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/cid\/cir1038","volume":"54","author":"MS Gable","year":"2012","unstructured":"Gable MS, Sheriff H, Dalmau J et al (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis 54(7):899\u2013904","journal-title":"Clin Infect Dis"},{"key":"15_CR124","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63\u201374","journal-title":"Lancet Neurol"},{"key":"15_CR125","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"15_CR126","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","volume":"258","author":"MS Zandi","year":"2011","unstructured":"Zandi MS, Irani SR, Lang B et al (2011) Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 258:686\u2013688","journal-title":"J Neurol"},{"key":"15_CR127","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/mds.22073","volume":"23","author":"TJ Kleinig","year":"2008","unstructured":"Kleinig TJ, Thompson PD, Matar W et al (2008) The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 23:1256\u20131261","journal-title":"Mov Disord"},{"key":"15_CR128","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167\u2013177","journal-title":"Lancet Neurol"},{"key":"15_CR129","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-2094-6-31","volume":"6","author":"KE Hill","year":"2009","unstructured":"Hill KE, Clawson SA, Rose JW et al (2009) Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation 6:31","journal-title":"J Neuroinflammation"},{"issue":"4","key":"15_CR130","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1212\/WNL.0000000000001792","volume":"85","author":"Y Hacohen","year":"2015","unstructured":"Hacohen Y, Zuberi S, Vincent A et al (2015) Neuromyelitis optica in a child with Aicardi-Gouti\u00e8res syndrome. Neurology 85(4):381\u2013383","journal-title":"Neurology"},{"issue":"11","key":"15_CR131","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","volume":"79","author":"SE Schmitt","year":"2012","unstructured":"Schmitt SE, Pargeon K, Frechette ES et al (2012) Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79(11):1094\u20131100","journal-title":"Neurology"},{"issue":"4","key":"15_CR132","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/practneurol-2016-001380","volume":"16","author":"A Abbas","year":"2016","unstructured":"Abbas A, Garg A, Jain R et al (2016) Extreme delta brushes and BIRDs in the EEG of anti-NMDA-receptor encephalitis. Pract Neurol 16(4):326\u2013327","journal-title":"Pract Neurol"},{"key":"15_CR133","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/1550059417693168","volume":"49","author":"B Baykan","year":"2018","unstructured":"Baykan B, Gungor Tuncer O, Vanli-Yavuz EN et al (2018) Delta brush pattern is not unique to NMDAR encephalitis: evaluation of two independent long-term EEG cohorts. Clin EEG Neurosci 49:278\u2013284","journal-title":"Clin EEG Neurosci"},{"key":"15_CR134","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","volume":"83","author":"F Leypoldt","year":"2012","unstructured":"Leypoldt F, Buchert R, Kleiter I et al (2012) Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry 83:681\u2013686","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR135","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","volume":"70","author":"J Steiner","year":"2013","unstructured":"Steiner J, Walter M, Glanz W et al (2013) Increased prevalence of diverse N -methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia. JAMA Psychiat 70:271","journal-title":"JAMA Psychiat"},{"key":"15_CR136","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00406-014-0493-9","volume":"264","author":"S Busse","year":"2014","unstructured":"Busse S, Busse M, Brix B et al (2014) Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients. Eur Arch Psychiatry Clin Neurosci 264:545\u2013550","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"15_CR137","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1161\/STROKEAHA.114.008323","volume":"46","author":"M Zerche","year":"2015","unstructured":"Zerche M, Weissenborn K, Ott C et al (2015) Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke. Stroke 46:1180\u20131186","journal-title":"Stroke"},{"key":"15_CR138","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/acn3.120","volume":"1","author":"S Doss","year":"2014","unstructured":"Doss S, Wandinger K-P, Hyman BT et al (2014) High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types. Ann Clin Transl Neurol 1:822\u2013832","journal-title":"Ann Clin Transl Neurol"},{"key":"15_CR139","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.24189","volume":"76","author":"L Dahm","year":"2014","unstructured":"Dahm L, Ott C, Steiner J et al (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 76:82\u201394","journal-title":"Ann Neurol"},{"key":"15_CR140","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clinbiochem.2016.11.023","volume":"50","author":"M Gastaldi","year":"2017","unstructured":"Gastaldi M, Thouin A, Franciotta D et al (2017) Pitfalls in the detection of N -methyl- d -aspartate-receptor (NMDA-R) antibodies. Clin Biochem 50:354\u2013355","journal-title":"Clin Biochem"},{"key":"15_CR141","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/jnnp-2014-308736","volume":"86","author":"MS Zandi","year":"2015","unstructured":"Zandi MS, Paterson RW, Ellul MA et al (2015) Clinical relevance of serum antibodies to extracellular N -methyl-d-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry 86:708\u2013713","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"16","key":"15_CR142","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","volume":"90","author":"M Hara","year":"2018","unstructured":"Hara M, Martinez-Hernandez E, Ari\u00f1o H et al (2018) Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor. Neurology 90(16):e1386\u2013e1394","journal-title":"Neurology"},{"key":"15_CR143","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamaneurol.2013.585","volume":"70","author":"H-C Hansen","year":"2013","unstructured":"Hansen H-C, Klingbeil C, Dalmau J et al (2013) Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 70:117\u2013119","journal-title":"JAMA Neurol"},{"key":"15_CR144","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1212\/WNL.0000000000000126","volume":"82","author":"A Viaccoz","year":"2014","unstructured":"Viaccoz A, Desestret V, Ducray F et al (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556\u2013563","journal-title":"Neurology"},{"key":"15_CR145","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/art.22031","volume":"54","author":"L Lapteva","year":"2006","unstructured":"Lapteva L, Nowak M, Yarboro CH et al (2006) Anti\u2013N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 54:2505\u20132514","journal-title":"Arthritis Rheum"},{"key":"15_CR146","doi-asserted-by":"publisher","first-page":"e3347","DOI":"10.1371\/journal.pone.0003347","volume":"3","author":"H Fragoso-Loyo","year":"2008","unstructured":"Fragoso-Loyo H, Cabiedes J, Orozco-Narv\u00e1ez A et al (2008) Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 3:e3347","journal-title":"PLoS One"},{"key":"15_CR147","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/art.22030","volume":"54","author":"MJ Harrison","year":"2006","unstructured":"Harrison MJ, Ravdin LD, Lockshin MD (2006) Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 54:2515\u20132522","journal-title":"Arthritis Rheum"},{"key":"15_CR148","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/0961203307078224","volume":"16","author":"G Steup-Beekman","year":"2007","unstructured":"Steup-Beekman G, Steens S, van Buchem M et al (2007) Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus 16:329\u2013334","journal-title":"Lupus"},{"key":"15_CR149","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamaneurol.2014.30","volume":"71","author":"F Graus","year":"2014","unstructured":"Graus F, Dalmau J (2014) Neuronal antibodies in Creutzfeldt-Jakob disease\u2014reply. JAMA Neurol 71:514\u2013515","journal-title":"JAMA Neurol"},{"key":"15_CR150","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/B978-0-444-63432-0.00012-8","volume":"133","author":"MA Bruijn De","year":"2016","unstructured":"De Bruijn MA, Titulaer MJ (2016) Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathies. Handb Clin Neurol 133:199\u2013217","journal-title":"Handb Clin Neurol"},{"key":"15_CR151","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, van Sonderen A, Leypoldt F et al (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84:2403\u20132412","journal-title":"Neurology"},{"key":"15_CR152","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.24293","volume":"77","author":"X Peng","year":"2015","unstructured":"Peng X, Hughes EG, Moscato EH et al (2015) Cellular plasticity induced by anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol 77:381\u2013398","journal-title":"Ann Neurol"},{"key":"15_CR153","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.8036512","volume":"265","author":"SW Rogers","year":"1994","unstructured":"Rogers SW, Andrews PI, Gahring LC et al (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen\u2019s encephalitis. Science 265:648\u2013651","journal-title":"Science"},{"key":"15_CR154","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1212\/WNL.0b013e31828ab325","volume":"80","author":"A Mat","year":"2013","unstructured":"Mat A, Adler H, Merwick A et al (2013) Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF. Neurology 80:1349\u20131350","journal-title":"Neurology"},{"key":"15_CR155","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola M, Sabater L, Planaguma J et al (2018) Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology 90:e1964\u2013e1972","journal-title":"Neurology"},{"key":"15_CR156","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0140-6736(82)91887-6","volume":"319","author":"I Carr","year":"1982","unstructured":"Carr I (1982) The Ophelia syndrome: memory loss in Hodgkin\u2019s disease. Lancet 319:844\u2013845","journal-title":"Lancet"},{"key":"15_CR157","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Rosenfeld MR, Saiz A et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404","journal-title":"Lancet Neurol"},{"key":"15_CR158","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/brain\/awq113","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Bera K, Waters P et al (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655\u20131667","journal-title":"Brain"},{"issue":"6","key":"15_CR159","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1212\/NXI.0000000000000404","volume":"4","author":"L McCracken","year":"2017","unstructured":"McCracken L, Zhang J, Greene M et al (2017) Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 4(6):e404","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"15_CR160","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257:509\u2013517","journal-title":"J Neurol"},{"key":"15_CR161","unstructured":"Karim A, Egner W, Patel D et al (2016) International consensus: paraneoplastic neurological antibodies\u2014are we there yet? J Clin Exp Neuroimmunol 1(1). \n                    https:\/\/www.omicsonline.org\/open-access\/international-consensus-paraneoplastic-neurological-antibodies%2D%2Dare-we-thereyet-jceni-1000105.pdf"},{"issue":"7","key":"15_CR162","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","volume":"8","author":"E Lancaster","year":"2012","unstructured":"Lancaster E, Dalmau J (2012) Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 8(7):380\u2013390","journal-title":"Nat Rev Neurol"},{"key":"15_CR163","first-page":"329","volume":"35","author":"K-P Wandinger","year":"2011","unstructured":"Wandinger K-P, Klingbeil C, Gneiss C et al (2011) Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis\/New serological markers for the differential diagnosis of autoimmune limbic encephalitis. J Lab Med 35:329\u2013342","journal-title":"J Lab Med"},{"key":"15_CR164","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH, Zeng C et al (2011) Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22:1137\u20131143","journal-title":"J Am Soc Nephrol"},{"key":"15_CR165","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/cei.12185","volume":"175","author":"F Leypoldt","year":"2014","unstructured":"Leypoldt F, Wandinger KP (2014) Paraneoplastic neurological syndromes. Clin Exp Immunol 175:336\u2013348","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"15_CR166","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1212\/WNL.0b013e318211c379","volume":"76","author":"A McKeon","year":"2011","unstructured":"McKeon A, Pittock SJ, Lennon VA (2011) CSF complements serum for evaluations paraneoplastic antibodies and NMO-IgG. Neurology 76(12):1108\u20131110","journal-title":"Neurology"},{"key":"15_CR167","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jneuroim.2013.09.017","volume":"265","author":"Y Hachiya","year":"2013","unstructured":"Hachiya Y, Uruha A, Kasai-Yoshida E et al (2013) Rituximab ameliorates anti-N-methyl-D-aspartate receptor encephalitis by removal of short-lived plasmablasts. J Neuroimmunol 265:128\u2013130","journal-title":"J Neuroimmunol"},{"key":"15_CR168","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1352458515587752","volume":"22","author":"IH Jeong","year":"2016","unstructured":"Jeong IH, Park B, Kim S-H et al (2016) Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints. Mult Scler 22:329\u2013339","journal-title":"Mult Scler"},{"key":"15_CR169","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamaneurol.2013.5699","volume":"71","author":"MA Mealy","year":"2014","unstructured":"Mealy MA, Wingerchuk DM, Palace J et al (2014) Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy. JAMA Neurol 71:324\u2013330","journal-title":"JAMA Neurol"},{"key":"15_CR170","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1600-0412.2011.01365.x","volume":"91","author":"JL Tanyi","year":"2012","unstructured":"Tanyi JL, Marsh EB, Dalmau J et al (2012) Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms. Acta Obstet Gynecol Scand 91:630\u2013634","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Methods in Molecular Biology","Glutamate Receptors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9077-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T05:09:55Z","timestamp":1558069795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9077-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493990764","9781493990771"],"references-count":170,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9077-1_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"2 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}